Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.43M Buy
4,053
+327
+9% +$117K 0.15% 87
2025
Q4
$1.22M Buy
3,726
+56
+2% +$17.8K 0.14% 92
2025
Q3
$1.04M Buy
3,670
+8
+0.2% +$2.32K 0.13% 101
2025
Q2
$1.02M Sell
3,662
-78
-2% -$22.1K 0.14% 100
2025
Q1
$1.17M Buy
3,740
+159
+4% +$47K 0.18% 87
2024
Q4
$933K Buy
3,581
+21
+0.6% +$6.23K 0.15% 93
2024
Q3
$1.15M Buy
3,560
+31
+0.9% +$10.1K 0.19% 84
2024
Q2
$1.1M Buy
3,529
+603
+21% +$177K 0.2% 79
2024
Q1
$832K Buy
2,926
+1
+0% +$293 0.15% 97
2023
Q4
$842K Buy
2,925
+267
+10% +$72.7K 0.16% 92
2023
Q3
$714K Sell
2,658
-131
-5% -$32.7K 0.16% 102
2023
Q2
$619K Buy
2,789
+480
+21% +$111K 0.13% 112
2023
Q1
$558K Sell
2,309
-94
-4% -$23.1K 0.12% 115
2022
Q4
$631K Sell
2,403
-5
-0.2% -$1.34K 0.15% 97
2022
Q3
$543K Buy
2,408
+921
+62% +$223K 0.15% 102
2022
Q2
$362K Buy
1,487
+65
+5% +$15.9K 0.1% 112
2022
Q1
$344K Buy
1,422
+345
+32% +$79.3K 0.08% 128
2021
Q4
$242K Buy
1,077
+644
+149% +$136K 0.06% 155
2021
Q3
$110K Sell
433
-704
-62% -$162K 0.08% 116
2021
Q2
$277K Buy
1,137
+134
+13% +$33K 0.08% 130
2021
Q1
$250K Buy
1,003
+570
+132% +$136K 0.09% 112
2020
Q4
$100K Hold
433
0.06% 131
2020
Q3
$110K Hold
433
0.08% 116
2020
Q2
$102K Buy
433
+127
+42% +$29K 0.08% 113
2020
Q1
$62K Buy
+306
New +$66.8K 0.06% 128

Other funds holding AMGN

CVA Family Office's AMGN Position: Q1 2026 in Review

CVA Family Office increased its Amgen (AMGN) stake by 8.8% in Q1 2026, buying an estimated $117K and bringing the position to 4,053 shares worth $1.43M. The position accounts for 0.15% of the portfolio, ranked #87.

CVA Family Office first reported a position in AMGN in Q1 2020 and has held it in 25 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • CVA Family Office held 4,053 shares of Amgen worth $1.43M as of Q1 2026.
  • CVA Family Office bought 327 Amgen shares in Q1 2026, an estimated $117K.
  • Amgen made up 0.15% of CVA Family Office's portfolio in Q1 2026, its #87 holding.
  • CVA Family Office first reported a position in Amgen in Q1 2020 and has held it in 25 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.